ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/24/2025
Back to search
Official data from USPTO
LENTIBONE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
01/29/2025
Trademark type
Word
Nice classes
42
Filing date
06/20/2022
Registration date
08/08/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/08/2023
Last transaction
01/29/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
CN
Examiner
BRADLEY, EVELYN
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Z. P. (pessoa física)
Jiangsu GenScript Probio Biotech Co., Ltd.
Representatives
BEIJING JINCHENG TONGDA & NEAL LAW FIRM
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Technological research in the field of gene synthesis; research and development of new products for others; scientific laboratory services; biochemical research; biological research; biomedical research services; pharmaceutical research services; bacteriological research; structural and functional analysis of genomes; medical and scientific researchconducting clinical trials for others; research and development services in the field of antibodies; development of pharmaceutical preparations and medicines; testing of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
21 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/20/2024
GPNX
NOTIFICATION PROCESSED BY IB
10/15/2023
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
09/18/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
09/18/2023
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
09/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/08/2023
GPNX
NOTIFICATION PROCESSED BY IB
05/24/2023
PUBO
PUBLISHED FOR OPPOSITION
05/23/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/03/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/03/2023
NPUB
NOTICE OF PUBLICATION
05/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/18/2023
DOCK
ASSIGNED TO EXAMINER
03/30/2023
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
01/10/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
10/24/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/30/2022
MAFR
APPLICATION FILING RECEIPT MAILED
09/13/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/07/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/06/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/01/2022
Continuous trademark protection
Get notified about every new filing that threatens LENTIBONE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.